Epileptic Disorders
MENURufinamide for the treatment of Lennox-Gastaut syndrome: evidence from clinical trials and clinical practice Volume 20, numéro 1, February 2018
Citer cet article
Citation de l'article, à la forme « Vancouver » :
Pasquale Striano, Rob McMurray, Estevo Santamarina, Mercè Falip. Rufinamide for the treatment of Lennox-Gastaut syndrome: evidence from clinical trials and clinical practice. Epileptic Disorders. 2018;20(1):13-29. doi:10.1684/epd.2017.0950